Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
64
datasets available to search
ShareScore release 0.9.0
Dataset results
64 results for “light chain amyloidosis”
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
ClinicalTrials.gov study NCT01659658. IPD Sharing: YES. Countries: 15. Publications: 2.
Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis
ClinicalTrials.gov study NCT01318902. IPD Sharing: YES. Countries: 5. Publications: 1.
Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis
ClinicalTrials.gov study NCT01864018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis
ClinicalTrials.gov study NCT00298766. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Doxycycline to Upgrade Organ Response in Light Chain (AL) Amyloidosis Trial
ClinicalTrials.gov study NCT02207556. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
ClinicalTrials.gov study NCT05199337. IPD Sharing: NO. Countries: 7. Publications: 1.
A Trial for Systemic Light-chain (AL) Amyloidosis
ClinicalTrials.gov study NCT01277016. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of HBI0101 (NXC-201) CAR-T Therapy in Multiple Myeloma and Light-Chain Amyloidosis
ClinicalTrials.gov study NCT06971380. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis
ClinicalTrials.gov study NCT01707264. IPD Sharing: Not stated. Countries: 1. Publications: 1.
FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
ClinicalTrials.gov study NCT05978661. IPD Sharing: NO. Countries: 1. Publications: 0.
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
ClinicalTrials.gov study NCT04270175. IPD Sharing: NO. Countries: 1. Publications: 1.
Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemotherapy
ClinicalTrials.gov study NCT05448716. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis
ClinicalTrials.gov study NCT00621400. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis
ClinicalTrials.gov study NCT04131309. IPD Sharing: NO. Countries: 4. Publications: 0.
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
ClinicalTrials.gov study NCT05652335. IPD Sharing: YES. Countries: 7. Publications: 1.
Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis
ClinicalTrials.gov study NCT04847453. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis
ClinicalTrials.gov study NCT06097832. IPD Sharing: NO. Countries: 1. Publications: 3.
BCD With or Without Doxycycline in Mayo Stage II-III Light Chain Amyloidosis Patients
ClinicalTrials.gov study NCT03401372. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
ClinicalTrials.gov study NCT05452850. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Nutritional Counseling in Systemic Immunoglobulin Light-chain Amyloidosis
ClinicalTrials.gov study NCT02055534. IPD Sharing: Not stated. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.